Table 2.
Univariate analysis of patients subject to recidivism
| 30-day recidivism | 30–90-day recidivism | 90-day recidivism | |
|---|---|---|---|
| Gender, n (%) | |||
| Male | 8/60 (13.3%) | 14/53 (26.4%) | 18/66 (27.3%) |
| Female | 10/56 (17.9%) | 9/49 (18.4%) | 16/59 (27.1%) |
| Race, n (%) | |||
| African American | 1/8 (12.5%) | 2/7 (28.6%) | 2/9 (22.2%) |
| White | 17/100 (17.0%) | 19/88 (21.6%) | 30/106 (28.3%) |
| Asian American | 0/2 (0%) | 1/2 (50.0%) | 1/2 (50.0%) |
| Other | 0/6 (0%) | 1/5 (20.0%) | 1/8 (12.5%) |
| Smoking status, n (%) | |||
| Current | 3/25 (12%) | 5/23 (21.7%) | 6/29 (20.7%) |
| Prior | 6/29 (20.7%) | 6/26 (23.1%) | 9/32 (38.1%) |
| Never | 9/59 (15.3%) | 12/53 (22.6%) | 19/64 (29.7%) |
| COPD, n (%) | 0/9 (0%) | 1/7 (14.3%) | 1/10 (10.0%) |
| Diabetes, n (%) | 4/28 (14.3%) | 5/22 (21.6%) | 8/31 (25.8%) |
| Hypertension, n (%) | 10/48 (20.8%) | 12/43 (27.9%) | 19/53 (35.9%) |
| Heart disease, n (%) | 2/20 (10.0%) | 5/18 (27.8%) | 6/23 (26.1%) |
| Steroid use, n (%) | 0/4 (0%) | 2/4 (50.0%) | 2/4 (50.0%) |
| Chronic pancreatitis, n (%) | 9/21 (42.9%)a | 5/17 (29.4%) | 10/21 (47.6%)a |
| Stent, n (%) | 7/52 (13.5%) | 10/44 (22.7%) | 15/56 (26.8%) |
| Transfusion, n (%) | 4/24 (16.7%) | 13/23 (56.5%)a | 14/30 (46.7%)a |
| Whipple type, n (%) | |||
| Pylorus-preserving PD | 0/2 (0%) | 0/2 (0%) | 0/2 (0%) |
| Standard PD | 18/114 (15.6%) | 23/100 (23.0%) | 34/122 (27.6%) |
a
P < 0.05.
Denominators differ in the three columns because each readmission was treated independently.
COPD, chronic obstructive pulmonary disease; PD, pancreaticoduodenectomy.